Frank Vermassen, UZ Gent, Belgium
|09:35||Session 1: Controversies in the management of lung cancer
Chairs: Veerle Surmont, UZ Gent & Christian Rolfo, UZA
|09:35||Hadron therapy in lung cancer
Wilfried Deneve, UZ Gent, Belgium
|10:00||Debate: EGFR-TKI’s going wild
Pro: Treatment for all comers
Annelies Janssens, UZ Antwerp, Belgium
Con: TAILORed treatment
Marina Garassino, Istituto Tumori-Milano, Italy
|10:30||Smoking cessation in patients with (lung) cancer: does it matter?
Wanda de Kanter, NKI, Amsterdam, The Netherlands
|11:30||Session 2: Cancer immunotherapy: back to the future?
Chairs: Birgitta Hiddinga, UZA & Thomas Malfait, UZ Gent
|11:30||Checkpoint immunotherapy with monoclonal antibodies
Mary O’Brien, Royal Marsden Hospital, London, UK
Karim Vermaelen, UZ Gent, Belgium
|12:25||Clinical experience with vaccination against MUC-1 glycoprotein
Charles Butts, Department of Oncology, University of Alberta, Alberta, Canada
Jan van Meerbeeck, UZA, Belgium
We are delighted to invite you to our 10th Thoracic Oncology Winter symposium on January 18, 2014.
This jubilee edition of our annual symposium offers a unique opportunity to meet (inter)national experts in thoracic oncology and discuss challenging controversies and promising innovations in the field, e.g immuno- and hadrontherapy.
Pencil the date in your brand new 2014 agenda, don’t miss this experience and take the opportunity to visit and shop in Ghent after the meeting. There are some great sales opportunities…
We look forward to meet you in Ghent,
Prof. Dr . J. van Meerbeeck, Coördinator Thoraxoncologie, MOCA UZA
Prof. Dr . V. Surmont, Coördinator LONG